World Journal of Gastrointestinal Oncology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 40

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1802)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-1) series.

Item

Count

PDF

124

HTML

543

Tables (1-1)

Sum=714

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

274

Download

265

Sum=539

Publishing Process of This Article

Item

Count

Browse

171

Download

256

Sum=427

Oct 28, 2025 (publication date) through Apr 1, 2026

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Isakov V, Goncharov A. Breaking barriers in the first-line Helicobacter pylori treatment: Chinese multicenter trial validates vonoprazan-based triple therapy. World J Gastroenterol 2025; 31(40): 112312 [PMID: 41180991 DOI: 10.3748/wjg.v31.i40.112312]
URL:	https://www.wjgnet.com/1948-5204/full/v31/i40/112312.htm

Number	Citing Articles
1	Shuang-Yan He, Yan Ma, Yuan-Qing He, Xia Ai, Hua Zhang, Yi-Hong Mao, Wei Li, Li-Li Wu, Yan Zhang, Cheng-Gang Zhang, Guo-Bing Zhu, Lian Hu, Cheng-Kui Dong, Kai Jiang, Lin-Lin Chen, Lei Deng, Shun-Bin Ding, Zong-Hua Chen, Qing-Ling He, Chang-Ping Li, Xiu Zhou, Chao-Qun Wu. Regional multi-center randomized trial of three vonoprazan-amoxicillin dosing regimens for <i>Helicobacter pylori</i> eradication in Sichuan Province, China. World Journal of Gastroenterology 2025; 31(47): 114377 doi: 10.3748/wjg.v31.i47.114377 Abstract(61) \| Core Tip(52) \| Full Article(HTML)(414) \| Full Article with Cover (PDF)-808K(77) \| Audio-794K(7) \| Peer-Review Report-237K(20) \| Answering Reviewers-163K(14) \| Full Article (PDF)-555K(64) \| Full Article (XML)-125K(16) \| Times Cited (1) \| Total Visits (1978) \| Open

Number

Citing Articles

Shuang-Yan He, Yan Ma, Yuan-Qing He, Xia Ai, Hua Zhang, Yi-Hong Mao, Wei Li, Li-Li Wu, Yan Zhang, Cheng-Gang Zhang, Guo-Bing Zhu, Lian Hu, Cheng-Kui Dong, Kai Jiang, Lin-Lin Chen, Lei Deng, Shun-Bin Ding, Zong-Hua Chen, Qing-Ling He, Chang-Ping Li, Xiu Zhou, Chao-Qun Wu. Regional multi-center randomized trial of three vonoprazan-amoxicillin dosing regimens for <i>Helicobacter pylori</i> eradication in Sichuan Province, China. World Journal of Gastroenterology 2025; 31(47): 114377 doi: 10.3748/wjg.v31.i47.114377